Theseus Pharmaceuticals, Inc.

THRX · NASDAQ
Analyze with AI
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Operating Activities
Net Income-$51-$27-$12-$7
Dep. & Amort.$0$0$0$0
Deferred Tax$0-$4$0$0
Stock-Based Comp.$11$4$1$0
Change in WC$7-$4$1-$0
Other Non-Cash-$0$4$5$2
Operating Cash Flow-$33-$27-$5-$5
Investing Activities
PP&E Inv.-$0$0$0$0
Net Acquisitions$0$0$0$0
Inv. Purchases-$191$0$0$0
Inv. Sales/Matur.$75$0$0$0
Other Inv. Act.-$0$0$0$0
Investing Cash Flow-$117$0$0$0
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$0$166$12$3
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$264$12$3
Financing Cash Flow$0$264$12$3
Forex Effect$0-$0$0$0
Net Chg. in Cash-$150$237$7-$2
Supplemental Information
Beg. Cash$245$8$1$3
End Cash$95$245$8$1
Free Cash Flow-$33-$27-$5-$5